Latest / The Well-Built Life / The NAD Supplement Dilemma: Is It Worth the Hype?
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell alongside Thomas Bennett and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules and
- 0:14Speaker 1: share simple practical habits that help you feel stronger, healthier
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get
- 0:22Speaker 1: comfortable and let's dive in. So let's dive into the
- 0:25Speaker 1: heart of NAD before we get too deep. For those
- 0:29Speaker 1: tuning in, NAD stands for nicotinamide adenine denucleotide, and it's
- 0:34Speaker 1: a key molecule in cellular metabolism. It's all about energy production,
- 0:39Speaker 1: DNA repair, and even circadian rhythms.
- 0:42Speaker 2: Exactly. And it's fascinating how NAD has moved from a
- 0:46Speaker 2: mere scientific curiosity to a hot topic in longevity research.
- 0:50Speaker 2: Back in the 1980s, David Sinclair was among the first
- 0:55Speaker 2: to look seriously at NAD in the context of aging.
- 0:59Speaker 2: His work laid the groundwork for what we know today. Right.
- 1:02Speaker 1: Sinclair's research began to gain traction in the late 1990s.
- 1:06Speaker 1: He started to link NAD decline with aging processes. Fast
- 1:11Speaker 1: forward to 2006, we see the formation of Sirtris Pharmaceuticals.
- 1:16Speaker 1: This was the moment when NAD began, not just as
- 1:19Speaker 1: a scientific pursuit, but as a potential commercial opportunity.
- 1:23Speaker 2: Yes, and with its acquisition by GlaxoSmithKline in 2007 for
- 1:27Speaker 2: a whopping $ 720 million, the market for NAD supplements was
- 1:32Speaker 2: poised for a big push. But here is the interesting part.
- 1:36Speaker 2: Within six months, the FDA reclassified NAD containing products as
- 1:40Speaker 2: investigational drugs. That was a game changer.
- 1:44Speaker 1: Absolutely. This shifted the regulatory playing field and brought into
- 1:49Speaker 1: question the legitimacy of the NAD. based products marketed by
- 1:53Speaker 1: companies like Sirtris. But let's fast forward to the consumer level.
- 1:57Speaker 1: From 2015, NAD supplements and IV drips became a multi-million
- 2:02Speaker 1: dollar industry, heavily promoted by Sinclair's public appearances.
- 2:07Speaker 2: Yet, the efficacy of these products is far from settled.
- 2:10Speaker 2: In one study, niacin was shown to increase NAD levels
- 2:14Speaker 2: by 5 to 8 times, while expensive NAD supplements only
- 2:19Speaker 2: increased them 2 times. And here is another shocker. High-cost
- 2:24Speaker 2: IV drips only increased NAD levels by 2%. That's quite
- 2:28Speaker 2: a contrast, isn't it?
- 2:30Speaker 1: Indeed, it's a stark illustration of the gap between what's
- 2:33Speaker 1: hyped and the actual science. But moving on, what about
- 2:37Speaker 1: the impact on healthy individuals who are taking these supplements?
- 2:41Speaker 1: Do they even need them?
- 2:43Speaker 2: That's a great question. Several studies suggest that NAD levels
- 2:47Speaker 2: in healthy individuals don't necessarily drop with age. In fact,
- 2:51Speaker 2: the benefits of supplementation are often questioned, especially when there
- 2:55Speaker 2: are cheaper and potentially more effective alternatives like niacin.
- 2:59Speaker 1: Perfect segue into our next point. That's exactly the point
- 3:03Speaker 1: we need to educate consumers. It's not just about the
- 3:07Speaker 1: science but also about understanding the potential side effects and costs.
- 3:12Speaker 1: The whole market seems to be a bit of a
- 3:14Speaker 1: wild west right now.
- 3:16Speaker 2: Exactly, and let's not forget the importance of regulatory oversight.
- 3:20Speaker 2: With such a rapidly growing market, we need robust measures
- 3:24Speaker 2: to protect public health. This brings us to the broader debate.
- 3:28Speaker 2: Where does the line between health and wellness truly lie?
- 3:31Speaker 1: Good question. As we look ahead, we can expect more
- 3:35Speaker 1: advanced research and perhaps stricter regulations. But for now, the
- 3:39Speaker 1: landscape is complex and filled with contradictions and uncertainties. It's
- 3:45Speaker 1: not just about the molecules, but how they are marketed,
- 3:48Speaker 1: and the claims made about them. Let's move into the
- 3:51Speaker 1: nitty-gritty of NAD supplementation and its alternatives. Research shows that
- 3:56Speaker 1: while supplements claim to boost NAD, natural methods could be
- 4:00Speaker 1: more effective and cheaper.
- 4:02Speaker 2: Absolutely. Take niacin, for instance. Studies demonstrate that it increases
- 4:07Speaker 2: NAD levels in the bloodstream up to 8-fold compared to
- 4:10Speaker 2: NAD supplements, which can only achieve 2-fold increases.
- 4:14Speaker 1: Right. So, We are looking at a potential 200% increase
- 4:19Speaker 1: with niacin flushing. And not only does it work better,
- 4:23Speaker 1: but it's a fraction of the cost.
- 4:25Speaker 2: Exactly. This brings up an interesting paradox, the effectiveness of
- 4:30Speaker 2: cheaper alternatives versus the high marketing costs. Nat supplements might
- 4:34Speaker 2: be more marketable due to their perceived exclusivity, but science
- 4:38Speaker 2: suggests they are not as efficient.
- 4:40Speaker 1: So, let's switch gears to regulatory challenges. The FDA's reclassification
- 4:46Speaker 1: of NAD, containing products as investigational drugs, was a turning point.
- 4:52Speaker 1: It highlighted the need for more stringent oversight.
- 4:54Speaker 2: Yes, and it also underscores the complexity. Companies like Sertris
- 4:59Speaker 2: Pharmaceuticals and GlaxoSmithKline had to navigate regulations while promoting their products.
- 5:04Speaker 2: This duality acting as both innovators and marketers creates a
- 5:08Speaker 2: confusing ecosystem for consumers.
- 5:10Speaker 1: That's a great point. The line between innovation and unregulated
- 5:14Speaker 1: marketing is thin. Companies have to walk a fine line
- 5:18Speaker 1: to avoid regulatory backlash while still driving demand.
- 5:22Speaker 2: True. Take their strategies, Certris, for example, used high-profile appearances
- 5:28Speaker 2: on podcasts like Joe Rogan to gain traction. It worked
- 5:32Speaker 2: wonders for public perception and product interest.
- 5:35Speaker 1: Right. But what about the long-term risks and side effects?
- 5:39Speaker 1: Research is still ongoing. and Turee's concern about potential side
- 5:43Speaker 1: effects from the expensive IV drips, which have seen limited
- 5:47Speaker 1: success compared to natural methods.
- 5:50Speaker 2: Absolutely. The debate isn't just about cost and efficacy. It's
- 5:54Speaker 2: about whether NAD supplementation is necessary at all for healthy individuals.
- 5:59Speaker 2: For those with diagnosed conditions, maybe. But for the general population,
- 6:03Speaker 2: lifestyle changes might be more impactful.
- 6:05Speaker 1: You make a valid point. The balance between marketing narratives
- 6:09Speaker 1: and scientific realities is key. As we look to the future,
- 6:13Speaker 1: more research will hopefully clarify the best approaches for boosting
- 6:17Speaker 1: NAD levels naturally.
- 6:18Speaker 2: Definitely. And with ongoing studies and regulatory changes, the landscape
- 6:23Speaker 2: will continue to evolve. It's a fascinating field with immense potential,
- 6:28Speaker 2: but we need to be smart about how we pursue it.
- 6:31Speaker 1: So, Thomas, we have touched on the potential pitfalls of
- 6:34Speaker 1: NAD supplements. But let's dive deeper into the regulatory landscape.
- 6:39Speaker 1: As we know, the FDA reclassified NAD containing products as
- 6:43Speaker 1: investigational drugs, which seems like a major shift. What do
- 6:47Speaker 1: you think this means for the industry and for consumers?
- 6:51Speaker 2: Absolutely. It's a pivotal moment. The FDA's action reflects the
- 6:55Speaker 2: broader debate on regulatory oversight in the wellness sector. But
- 6:59Speaker 2: let's step back and consider the implications. For consumers, it
- 7:03Speaker 2: means that these products are no longer simply sold as
- 7:06Speaker 2: health aids. The question now becomes, how do we navigate
- 7:10Speaker 2: this gray area between health and wellness?
- 7:13Speaker 1: Right, and that's the crucial nuance here. The distinction between
- 7:17Speaker 1: health and wellness can be very blurry. Take, for instance,
- 7:22Speaker 1: the IV NAD drips. They are marketed heavily for their
- 7:26Speaker 1: alleged anti-aging benefits. But with the new regulatory stance, Companies
- 7:32Speaker 1: might need to prove their products have substantial clinical evidence
- 7:36Speaker 1: backing their claims.
- 7:37Speaker 2: Exactly. This shift in regulation also highlights the importance of
- 7:42Speaker 2: transparency for consumers. They need to be aware that what
- 7:45Speaker 2: they are buying might not be regulated in the same
- 7:48Speaker 2: way as traditional pharmaceuticals. And it's important for them to
- 7:52Speaker 2: ask questions like, is there scientific evidence for these claims?
- 7:56Speaker 2: And how is the product made?
- 7:58Speaker 1: That's a great point. consumer education is so vital. Speaking
- 8:02Speaker 1: of which, there are voices like Dr. William Evans, who've
- 8:06Speaker 1: criticized the efficacy of NAD supplements. He claims that cheaper
- 8:11Speaker 1: alternatives like niacin can offer similar benefits. How do we
- 8:15Speaker 1: reconcile these differing opinions?
- 8:17Speaker 2: It's a bit of a paradox. On one hand, we
- 8:20Speaker 2: have experts like Dr. Evans pointing out that natural methods
- 8:23Speaker 2: might be just as effective and much more affordable. On
- 8:27Speaker 2: the other hand, Companies are still pushing these supplements, leveraging
- 8:30Speaker 2: the narrative of longevity and anti-aging. It's like a tug-of-war
- 8:35Speaker 2: between scientific skepticism and corporate strategy.
- 8:38Speaker 1: And Therese no clear winner. This debate underscores the need
- 8:42Speaker 1: for more robust consumer education. People need to understand that
- 8:46Speaker 1: what works for one might not for another. It's a
- 8:49Speaker 1: matter of personal experimentation and perhaps consulting with a healthcare provider.
- 8:54Speaker 2: Exactly. It's a complex mix of science, marketing, and personal responsibility.
- 9:00Speaker 2: The key is to foster an environment where consumers can
- 9:03Speaker 2: make informed decisions. Perhaps initiatives like public information campaigns and
- 9:08Speaker 2: education programs can help bridge this gap.
- 9:10Speaker 1: Agreed. And I think this discussion also points to another
- 9:14Speaker 1: critical issue. The long-term effects of NAD supplementation. While it's
- 9:19Speaker 1: clear that the short-term benefits might be questionable... it's important
- 9:23Speaker 1: to explore the potential long-term impacts, particularly for healthy individuals.
- 9:28Speaker 2: Right. The real value lies in ongoing research. As we
- 9:32Speaker 2: continue to learn more about NAD and its role in
- 9:35Speaker 2: aging and health, hopefully the landscape will become clearer. For now,
- 9:40Speaker 2: it's important to stay informed and be wary of quick
- 9:42Speaker 2: fixes and overly promising claims.
- 9:45Speaker 1: That's a well-stated point. So, as we wrap up, what's
- 9:49Speaker 1: the takeaway for our audience? How can they navigate this
- 9:52Speaker 1: landscape of NAD supplements?
- 9:54Speaker 2: First, they should be skeptical of any claims that seem
- 9:57Speaker 2: too good to be true. Second, they should seek out
- 10:00Speaker 2: credible sources of information and preferably consult with a healthcare professional.
- 10:05Speaker 2: And finally, they should remember that there are often simpler, safer,
- 10:10Speaker 2: and more cost-effective ways to boost their NAD levels. Exactly.
- 10:13Speaker 1: The key takeaway is balance and informed decision-making. With that,
- 10:19Speaker 1: we have hopefully provided some clarity on the complex world
- 10:22Speaker 1: of NAD supplementation. So, Thomas, let's dive into some of
- 10:27Speaker 1: the key unresolved questions about NAD. For instance, what are
- 10:31Speaker 1: the optimal intake levels for NAD supplementation, if any? And
- 10:36Speaker 1: are there non-supplementation methods that might be more effective?
- 10:39Speaker 2: Great question, Rachel. According to a study by researchers at
- 10:44Speaker 2: Tufts Center for Aging, the precise levels of NAD necessary
- 10:48Speaker 2: for optimal health are still under investigation. They suggest that
- 10:52Speaker 2: the idea of supplementing NAD just for preventive measures is
- 10:56Speaker 2: still premature. In contrast, there are natural ways to boost
- 11:00Speaker 2: NAD levels that might be more effective and safe.
- 11:04Speaker 1: Like what, Thomas? You mentioned natural methods. Can you elaborate?
- 11:09Speaker 2: Sure, Rachel. For example, niacin, also known as vitamin B3,
- 11:14Speaker 2: can increase NAD levels significantly. A study published in the
- 11:19Speaker 2: journal Cell found that niacin can increase NAD levels by
- 11:23Speaker 2: five to eight times compared to supplements. This makes it
- 11:26Speaker 2: a much cheaper and more accessible alternative. Moreover, lifestyle changes
- 11:31Speaker 2: such as regular exercise and a balanced diet rich in
- 11:35Speaker 2: B vitamins could also help.
- 11:37Speaker 1: Wait, but how does that actually play out in practice?
- 11:41Speaker 1: For instance, Can we just add a B-complex vitamin to
- 11:44Speaker 1: our morning smoothie and expect to see improvements?
- 11:48Speaker 2: It's a bit more nuanced than that, Rachel. While adding
- 11:51Speaker 2: a B-complex vitamin might provide some benefits, the effects may
- 11:55Speaker 2: vary based on individual dietary habits and gut health. For example,
- 12:00Speaker 2: the microbiome can impact NAD levels, and imbalances might need
- 12:04Speaker 2: to be addressed to see real improvements. That's why a
- 12:07Speaker 2: personalized approach might be key.
- 12:09Speaker 1: That's wild when you look at the raw numbers, Thomas.
- 12:12Speaker 1: But do we have any data on the long-term effects
- 12:14Speaker 1: of NAD supplementation? Or are we still in the realm
- 12:18Speaker 1: of speculation?
- 12:19Speaker 2: Right, exactly. The long-term effects are still not fully understood,
- 12:24Speaker 2: especially in healthy populations. There are concerns about potential side
- 12:28Speaker 2: effects of IV drips, which might not be necessary if
- 12:31Speaker 2: other methods are effective. A report from the journal Nature
- 12:34Speaker 2: highlighted that high-cost IV drips only increase NAD levels by 2%,
- 12:39Speaker 2: while inexpensive niacin performs better. This suggests that more research
- 12:44Speaker 2: is needed to fully understand the long-term effects and risks.
- 12:48Speaker 1: And what about the future research directions? Are there specific
- 12:53Speaker 1: avenues that the scientific community should focus on?
- 12:56Speaker 2: Absolutely. To raise a growing interest in understanding the precise
- 13:00Speaker 2: mechanisms of NAD in health and aging. For instance, some
- 13:05Speaker 2: researchers are exploring how NAD levels correlate with specific health
- 13:09Speaker 2: conditions like cognitive decline. Another promising area is the use
- 13:14Speaker 2: of NAD in therapy for chronic conditions. However, there needs
- 13:18Speaker 2: to be more robust, reproducible research to back these claims.
- 13:22Speaker 1: And how might this shift the industry landscape, Thomas? Are
- 13:26Speaker 1: we seeing any trends or shifts in how companies are
- 13:29Speaker 1: positioning NAD products?
- 13:31Speaker 2: The industry is definitely adjusting. Many companies that originally made
- 13:35Speaker 2: big claims are now focusing more on lifestyle products and
- 13:38Speaker 2: supplements that are easier to regulate. to raise a greater
- 13:42Speaker 2: emphasis on transparent marketing and evidence-based claims. With the FDA's scrutiny,
- 13:48Speaker 2: we are likely to see more regulated products hitting the market,
- 13:52Speaker 2: backed by stronger scientific evidence.
- 13:54Speaker 1: As we move towards the future of NAD, it's clear
- 13:57Speaker 1: that regulatory changes loom on the horizon. What do you
- 14:01Speaker 1: think is driving these shifts? Thomas.
- 14:04Speaker 2: It's a mix of factors, Rachel. On one hand, The
- 14:07Speaker 2: lack of robust reproducible research behind many NAD claims is
- 14:11Speaker 2: pushing the FDA to be more cautious. On the other hand,
- 14:14Speaker 2: consumer demand for anti-aging solutions is rising, creating a tension
- 14:18Speaker 2: between stringent regulation and market pressure.
- 14:20Speaker 1: Right, and that's the crucial nuance here. Companies are responding
- 14:24Speaker 1: by focusing on marketing supplements that are easier to regulate,
- 14:28Speaker 1: like lifestyle products. This shift can be seen in their
- 14:31Speaker 1: marketing strategies. Less emphasis on miracle cures. and more on
- 14:36Speaker 1: transparent claims backed by evidence.
- 14:38Speaker 2: Exactly, which brings up an interesting contradiction. While consumers are
- 14:43Speaker 2: increasingly health-conscious, they often gravitate towards quick fixes which can backfire.
- 14:48Speaker 2: For instance, nadivorf drips are often touted as a quick solution,
- 14:52Speaker 2: even though cheaper alternatives like niacin flushes outperform them in
- 14:56Speaker 2: terms of NID levels.
- 14:58Speaker 1: That's wild when you look at the raw numbers. A
- 15:00Speaker 1: study showed that niacin could increase NAD levels in the bloodstream.
- 15:05Speaker 1: up to eight times compared to NAD supplements. It makes
- 15:09Speaker 1: you wonder why the former hasn't taken off more in
- 15:12Speaker 1: the market.
- 15:13Speaker 2: Well, sometimes the premium pricing and marketing hype can drown
- 15:17Speaker 2: out practical benefits, and let's not forget about the placebo effect.
- 15:21Speaker 2: People might feel better just because they are paying a
- 15:23Speaker 2: lot for a perceived solution, even if the science isn't
- 15:26Speaker 2: fully there yet.
- 15:27Speaker 1: Agreed. Speaking of which, are there any specific areas where
- 15:32Speaker 1: the scientific community is focusing more research? Thomas?
- 15:36Speaker 2: Yes, there are. The gut microbiome is a hot topic.
- 15:39Speaker 2: Research suggests that gut health can significantly impact NAD levels. So,
- 15:45Speaker 2: improving gut health through lifestyle changes might be a more
- 15:48Speaker 2: effective and sustainable approach than supplements.
- 15:50Speaker 1: That's fascinating. How does this play out in practice? Can
- 15:54Speaker 1: you give us an example of how someone might practically
- 15:57Speaker 1: improve their gut health and potentially boost NAD levels?
- 16:01Speaker 2: For sure. Practices like probiotics, a diverse diet rich in fiber,
- 16:06Speaker 2: regular exercise, and reducing stress can all support a healthy
- 16:09Speaker 2: gut microbiome. For instance, a randomized controlled trial found that
- 16:14Speaker 2: participants who consumed a high fiber diet saw a significant
- 16:18Speaker 2: increase in NAD levels.
- 16:20Speaker 1: That's a practical takeaway. I think this points to the
- 16:23Speaker 1: broader message that when it comes to health and longevity,
- 16:27Speaker 1: natural methods might often be the best way to go.
- 16:32Speaker 1: as the future of the NAD market, Thomas.
- 16:35Speaker 2: I believe we will see a shift towards more evidence-based products.
- 16:39Speaker 2: As the scientific community continues to refine our understanding of NAD,
- 16:44Speaker 2: companies will likely focus on products that are backed by
- 16:47Speaker 2: rigorous research. Simultaneously, consumer behavior will likely change, favoring products
- 16:53Speaker 2: that are more transparent and grounded in science.
- 16:55Speaker 1: That is a hopeful outlook. Thank you, Thomas, for that
- 16:59Speaker 1: deep dive. As we wrap up, it seems the NAD
- 17:03Speaker 1: market is moving towards more practical, evidence-based options.
- 17:07Speaker 2: Absolutely, Rachel. And remember, always seek the best evidence before
- 17:11Speaker 2: making health decisions.
- 17:13Speaker 1: That brings us to the end of today's episode. Thank
- 17:15Speaker 1: you so much for spending part of your day with me.
- 17:19Speaker 1: If you found this episode's tips helpful and want to
- 17:21Speaker 1: make sure you don't miss the next conversation, please take
- 17:24Speaker 1: a quick second to hit that subscribe or follow button
- 17:27Speaker 1: on whatever platform you are listening on. It's a completely
- 17:31Speaker 1: free way to support the show and helps more people
- 17:33Speaker 1: find us. This podcast is independently produced, so if you
- 17:37Speaker 1: are ever in a position where you would like to
- 17:39Speaker 1: help keep it running, we do accept small donations. You
- 17:43Speaker 1: can find a link right in the episode description below
- 17:46Speaker 1: to buy us a coffee or contribute what you can.
- 17:49Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 17:54Speaker 1: and we will talk again soon.